Butalbital, Acetaminophen And Caffeine Capsule
Product Images NDC 13107-075

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Butalbital, Acetaminophen And Caffeine (NDC 13107-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurolife Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Butalbital Chemical Structure (But Ace Caff Str1)

FDA Label Image

Acetaminophen Chemical Structure (But Ace Caff Str2)

FDA Label Image

Caffeine Chemical Structure (But Ace Caff Str3)

FDA Label Image

Butalbitalacetaandcaffcaps.jpg (Butalbitalacetaandcaffcaps)

Butalbitalacetaandcaffcaps.jpg (Butalbitalacetaandcaffcaps)
This is a description of a prescription drug labeled NDC 13107-075-30, containing Butalbital, Acetaminophen, and Caffeine Capsules. It has 30 capsules per package and is manufactured by Aurobindo Pharma USA, Inc. The recommended adult dosage is one or two capsules every four hours, not exceeding six capsules daily. The drug should be stored in a tight, light-resistant container at a controlled room temperature. A child-resistant closure should be provided, and the medication should be kept out of the reach of children. The package insert should be reviewed for full prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.